... PubMed/MEDLINE, Web of Science, and EMBASE was conducted to identify articles published from 1960 to present that detail histology of initial biopsy and debulked tumor AbstractText: Fourteen studies, encompassing 2,565 cases of basalcellcarcinoma (BCC) and squamouscellcarcinoma (SCC) were included in the data extraction process.
Tumor PD-L1 expression has been associated with poor outcome in a wide variety of cancers; however, data in cutaneous squamouscellcarcinoma (cSCC) are scarce and conflicting AbstractText: To investigate the relationship of tumor PD-L1 expression with the clinicopathologic features and prognosis of ... Keyword: cutaneous squamouscellcarcinoma.
Oncology (5) Neoplasms (7), Squamous Cell Carcinoma (3), Head and Neck Neoplasms (1), more mentions
AbstractText: Perineural invasion (PNI) in cutaneous squamouscellcarcinoma (CSCC) has been associated with an increased risk of poor outcomes. Patients with PNI may present with clinical symptoms and/or radiologic evidence of PNI (clinical PNI [CPNI]), yet most patients are asymptomatic and PNI is often found on histologic examination (incidental PNI [IPNI.
... of the condition, studies concerning the management of patients with squamouscellcarcinoma of the anus with distant metastasis are scarce... multidisciplinary treatment on overall survival among patients presenting with metastatic squamouscellcarcinoma of the anus AbstractText: This was a retrospective study AbstractText ... Consecutive patients with histologically proven, newly diagnosed, or recurrent metastatic squamouscellcarcinoma of the anus were included AbstractText: Study interventions included multimodal ...
Oncology (4) Squamous Cell Carcinoma (5), Bone Neoplasms (1), Lung Neoplasms (1), more mentions
This study tested the hypothesis that increasing time between diagnosis and lobectomy for stage IA squamouscellcarcinoma (SCC) was associated with worse survival AbstractText: The association between timing of lobectomy and survival for patients with clinical stage IA SCC in the National Cancer Data Base (2006-2011) was assessed ...
Since the esophagus is easily accessible with endoscopy, early diagnosis and curative treatment of esophageal cancer is possible. However, diagnosis is often delayed because symptoms are not specific during early stages of tumor development. The onset of dysphagia is associated with advanced disease, and fewer than 15% of patients survive for 5 years. Population screening by endoscopy is not cost effective, but a number of alternative imaging and cell analysis technologies are under investigation. The ideal screening test should be inexpensive, well tolerated, and applicable to primary care. Over the last 10 years, significant progress has been made in endoscopic diagnosis and treatment of dysplasia (squamous and Barrett's), and early esophageal cancer using resection and ablation technologies supported by evidence from randomized controlled trials. We review the state-of-the-art technologies for early diagnosis and minimally invasive treatment, which together could reduce the burden of disease.
Abstract: Esophageal squamouscellcarcinoma (ESCC) is a common malignancy without effective therapy. The exomes of more than 600 ESCCs have been sequenced in the last 4 years, and numerous key aberrations have been identified(1-4. Recently, researchers reported both inter- and intra-tumor heterogeneity(5, 6. Although these are interesting observations, their clinical implications are unclear due to ...
AbstractText: Patients with platinum-refractory recurrent or metastatic squamouscellcarcinoma of the head and neck have few treatment options and ... label, phase 3 trial in patients with recurrent or metastatic squamouscellcarcinoma of the head and neck who progressed within 6 months ... investigator's choice in patients with platinum-refractory recurrent or metastatic squamouscellcarcinoma of the head and neck.
Oncology (2) Squamous Cell Carcinoma (5), Head and Neck Neoplasms (1), Neoplasms (1), more mentions
There have been concerns about the development of squamouscellcarcinoma (SCC) in patients treated with this drug AbstractText: We sought ... Covariates including age, sex, history of previous nonmelanomaskincancer, and number of visits per year were significantly associated with ... SCC when compared with standard surgical treatment of BCC Keyword: basalcellcarcinoma.
AbstractText: Nonmelanomaskincancers (NMSCs) of the ear are considered high risk... chart review of 649 consecutive patients treated with MMS at Mayo Clinic for primary cutaneous basalcellcarcinomas (BCCs) or squamouscellcarcinomas (SCCs) of the ear AbstractText: Nineteen percent of consecutively referred patients had NMSC of the ...
AbstractText: Protective effects of UV-B radiation against nonmelanomaskincancer (NMSC) are exerted via signaling mechanisms involving the vitamin D ... who received a diagnosis of and were being treated for basalcellcarcinoma or squamouscellcarcinoma (cases) and 100 individuals who were receiving treatment of a condition other than skincancer (controls) at the dermatology clinics at the Kirklin Clinic of ...
... Voriconazole has previously been associated with increased risk for cutaneous squamouscellcarcinoma (SCC) in solid organ transplant recipients... We evaluated the effect of voriconazole on the risk for nonmelanomaskincancer (NMSC), including SCC and basal cell carcionoma, among those who ... risk specifically for SCC in the allogeneic HCT population Keyword: basalcellcarcinoma... Keyword: nonmelanomaskincancer.
Abstract: Nonmelanomaskincancer (NMSC) comprises mainly basalcellcarcinoma (BCC) and cutaneous squamouscellcarcinoma (cSCC. The association between alcohol intake and NMSC has been inconclusive; therefore the objective of this study is to quantify the relationship between alcohol intake and NMSC using meta-analyses. A systematic literature search of PubMed and Embase was performed on 30 October 2016.
AbstractText: Epidermally limited nonmelanomaskincancer (ELNMSC) (superficial basalcellcarcinoma [SBCC] and squamouscellcarcinoma in situ [SCCIS]) is common. Data on outcomes and patient satisfaction are lacking AbstractText: To examine treatment efficacy and satisfaction in ELNMSC patients AbstractText: Retrospective cohort study of adults with primary SBCC or SCCIS.
To examine which attributes of a non-invasive treatment for superficial BCC (sBCC) are valued by patients, a discrete choice experiment (DCE) was performed alongside a clinical trial in which methylaminolevulinate photodynamic therapy (MAL-PDT), 5-fluorouracil and imiquimod were compared.(1) Treatment options were described by the following attributes: effectiveness, cosmetic result, treatment process and side-effects. Effectiveness was defined as the probability that complete tumour clearance is achieved 12 months after treatment with levels of 75%,80%,85% and 90%.(2-4) This article is protected by copyright. All rights reserved.